Evidence map›Paper›PMID 23422037›Full record

ReviewExperimental cell research2013

The role of semaphorins and their receptors in vascular development and cancer.

Chenghua Gu, Enrico Giraudo

Open access · greenAbstract readReview
In one paragraph

Review in Experimental cell research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Netrin-1 promotes epithelium repair in corneal injury.International journal of ophthalmology · 2020
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Chenghua GuDepartment of Neurobiology, Harvard Medical School, 220 Longwood Ave, Boston, MA 02115, USA. chenghua_gu@hms.harvard.edu
Enrico Giraudo
Candiolo Cancer Institute · ITHarvard University · US

Funding

The Role of Semaphorins in Axon and Blood Vessel GuidanceR01NS064583 · NINDS · HARVARD MEDICAL SCHOOL · PI GU, CHENGHUA · 2010 to 2014
$1.8M
NINDS NIH HHS R01 NS064583NINDS NIH HHS R01NS064583
6 · The paper itself

Abstract

Semaphorins (Semas) are a large family of traditional axon guidance molecules. Through interactions with their receptors, Plexins and Neuropilins, Semas play critical roles in a continuously growing list of diverse biological systems. In this review, we focus on their function in regulating vascular development. In addition, over the past few years a number of findings have shown the crucial role that Semas and their receptors play in the regulation of cancer progression and tumor angiogenesis. In particular, Semas control tumor progression by directly influencing the behavior of cancer cells or, indirectly, by modulating angiogenesis and the function of other cell types in the tumor microenvironment (i.e., inflammatory cells and fibroblasts). Some Semas can activate or inhibit tumor progression and angiogenesis, while others may have the opposite effect depending on specific post-translational modifications. Here we will also discuss the diverse biological effects of Semas and their receptor complexes on cancer progression as well as their impact on the tumor microenvironment.

Indexed as

AnimalsCell Adhesion MoleculesHumansNeoplasmsNeovascularization, PathologicNeovascularization, PhysiologicNerve Tissue ProteinsNeuropilinsSemaphorinsSignal TransductionTumor MicroenvironmentCell Adhesion MoleculesNerve Tissue ProteinsNeuropilinsplexinSemaphorins

Identifiers

PMID23422037
PMCPMC3648602
OpenAlexW2153213966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.